1,682
Views
1
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Review

Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis

ORCID Icon, , , , , & show all
Article: 2099700 | Received 04 Feb 2022, Accepted 06 Jul 2022, Published online: 21 Jul 2022

References

  • Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases In: Hall E,Wodi AP, Hamborsky J, et al., editors.) 14th ed. Washington (DC): Public Health Foundation, 2021. p. 1–10.
  • Hardy IR, Dittmann S, Sutter RW. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. The Lancet. 1996;347(9017):1739–1744. doi:10.1016/S0140-6736(96)90811-9.
  • Tiwari T, and Wharton M. Vaccines. In: Plotkin S, Orenstein W, editors. 7th ed. Philadelphia: W.B. Saunders Co; 2018.
  • Sein C, Tiwari T, Macneil A, Wannemuehler K, Soulaphy C, Souliphone P, Reyburn R, Ramirez Gonzalez A, Watkins M, Goodson JL. Diphtheria outbreak in Lao People’s Democratic Republic, 2012-2013. Vaccine. 2016;34(36):4321–4326. doi:10.1016/j.vaccine.2016.06.074.
  • Harapan H, Samsul A, Dimiati H, Hayati Z, Mudatsir M, et al. Diphtheria outbreak in Indonesia, 2017: an outbreak of an ancient and vaccine-preventable disease in the third millennium. Clin Epidemiol Global Health Journal Translated Name Clinical Epidemiology and Global Health. 2019;7(2):261–262. doi:10.1016/j.cegh.2018.03.007.
  • Wanlapakorn N, Yoocharoen P, Tharmaphornpilas P, Theamboonlers A, Poovorawan Y. Diphtheria outbreak in Thailand, 2012; seroprevalence of diphtheria antibodies among Thai adults and its implications for immunization programs. Southeast Asian J Trop Med Public Health. 2014;45:1132–1141.
  • Kitamura N, Le T, Le LT, Nguyen LD, Dao AT, Hoang TT, Yoshihara K, Iijima M, The TM, Do HM, et al. Diphtheria outbreaks in schools in central highland districts, Vietnam, 2015–2018. Emerg Infect Dis. 2020;26(3):596–600. doi:10.3201/eid2603.191027.
  • Belchior E, Henry S, Badell E, Collet L, Benoit-Cattin T, de Montera AM, Guiso N, Patey O, Levy-Bruhl D, Filleul L, et al. Diphtheria in Mayotte, 2007-2015. Emerg Infect Dis. 2017;23(7):1218–1220. doi:10.3201/eid2307.170262.
  • Besa NC, Coldiron ME, Bakri A, Raji A, Nsuami MJ, Rousseau C, Hurtado N, Porten K. Diphtheria outbreak with high mortality in northeastern Nigeria. Epidemiol Infect. 2014;142(4):797–802. doi:10.1017/S0950268813001696.
  • Mahomed S, Archary M, Mutevedzi P, Mahabeer Y, Govender P, Ntshoe G, Kuhn W, Thomas J, Olowolagba A, Blumberg L, et al. An isolated outbreak of diphtheria in South Africa, 2015. Epidemiol Infect. 2017;145(10):2100–2108. doi:10.1017/S0950268817000851.
  • Rahman MR, Islam K. Massive diphtheria outbreak among Rohingya refugees: lessons learnt. J Travel Med. 2019;26(1). doi:10.1093/jtm/tay122.
  • Page KR, Doocy S, Reyna Ganteaume F, Castro JS, Spiegel P, Beyrer C. Venezuela’s public health crisis: a regional emergency. Lancet. 2019;393(10177):1254–1260. doi:10.1016/S0140-6736(19)30344-7.
  • Clarke KEN, MacNeil A, Hadler S, Scott C, Tiwari TSP, Cherian T. Global epidemiology of diphtheria, 2000-2017(1). Emerg Infect Dis. 2019;25(10):1834–1842. doi:10.3201/eid2510.190271.
  • Fitzgerald JG, Defries RD, Fraser DT, Moloney PJ, McKinnon NE. Experiences with diphtheria toxoid in Canada. Am J Public Health Nations Health. 1932;22(1):25–28. doi:10.2105/AJPH.22.1.25.
  • WHO. Diphtheria vaccine: WHO position paper, August 2017 - recommendations. Vaccine; 2017.
  • WHO. Immunization, vaccines and biologicals, data, statistics and graphics 2021; [accessed 2021 Nov 23]. https://apps.who.int/immunization_monitoring/globalsummary.
  • Polonsky JA, Ivey M, Mazhar MKA, Rahman Z, le Polain de Waroux O, Karo B, Jalava K, Vong S, Baidjoe A, Diaz J, et al. Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox’s Bazar, Bangladesh, 2017 to 2019: a retrospective study. PLoS Med. 2021;18(4):e1003587. doi:10.1371/journal.pmed.1003587.
  • Badell E, Alharazi A, Criscuolo A, Almoayed KAA, Lefrancq N, Bouchez V, Guglielmini J, Hennart M, Carmi-Leroy A, Zidane N, et al. Ongoing diphtheria outbreak in Yemen: a cross-sectional and genomic epidemiology study. The Lancet Microbe. 2021;2(8):e386–e396. doi:10.1016/S2666-5247(21)00094-X.
  • Karyanti MR, Nelwan EJ, Assyidiqie IZ, Satari HI, Hadinegoro SR. Diphtheria epidemiology in Indonesia during 2010-2017. Acta Med Indones. 2019;51:205–213.
  • Arguni E, Karyanti MR, Satari HI, Hadinegoro SR. Diphtheria outbreak in Jakarta and Tangerang, Indonesia: epidemiological and clinical predictor factors for death. PLoS ONE. 2021;16(2 February):e0246301. doi:10.1371/journal.pone.0246301.
  • The Lancet Infectious Diseases. Infectious disease crisis in the Philippines. Lancet Infect Dis. 2019;19(12):1265. doi:10.1016/S1473-3099(19)30642-5.
  • Maramraj KK, Kaur S, Dikid T, Jain SK, Singh SK, Latha MLK, Reddy R, Reddy S, Sodha SV. Addressing reemergence of diphtheria among adolescents through program integration in India. Emerg Infect Dis. 2021;27(3):953–956. doi:10.3201/eid2703.203205.
  • Besa NC, Coldiron ME, Porten K, Bakri A, Raji A, Nsuami MJ, Rousseau C, Hurtado N. Diphtheria outbreak with high mortality in northeastern Nigeria. Epidemiol Infect. 2013;142(4):797–802. doi:10.1017/S0950268813001696.
  • Mahomed S, Archary M, Govender P, Kuhn W, Moodley P, Mutevedzi P, Thomas J, Blumberg L, Mlisana K, Mahabeer Y, et al. An isolated outbreak of diphtheria in South Africa, 2015. Epidemiol Infect. 2017;145(10):2100–2108. doi:10.1017/S0950268817000851.
  • Rakotomalala RS, Rabenandrianina T, Andrianirina ZZ, Andrianarimanana D, Ratsima E, Randrianirina F, Randrianandraina P, Edosoa GT, Badell E, Brisse S, et al. Corynebacterium diphtheriae infection in Mahajanga, Madagascar: first case report. J Trop Pediatr. 2021;67(1):fmaa064. doi:10.1093/tropej/fmaa064.
  • McIntyre PB, Burgess MA, Egan A, Schuerman L, Hoet B. Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination. Vaccine. 2009;27(7):1062–1066. doi:10.1016/j.vaccine.2008.11.102.
  • Weston W, Messier M, Friedland LR, Wu X, Howe B. Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine. Vaccine. 2011;29(47):8483–8486. doi:10.1016/j.vaccine.2011.09.063.
  • Hammarlund E, Thomas A, Poore EA, Amanna IJ, Rynko AE, Mori M, Chen Z, Slifka MK. Durability of vaccine-induced immunity against Tetanus and diphtheria toxins: a cross-sectional analysis. Clin Infect Dis. 2016;62(9):1111–1118. doi:10.1093/cid/ciw066.
  • Antia A, Ahmed H, Handel A, Carlson NE, Amanna IJ, Antia R, Slifka M, Rowland-Jones S. Heterogeneity and longevity of antibody memory to viruses and vaccines. PLoS Biol. 2018;16(8):e2006601. doi:10.1371/journal.pbio.2006601.
  • Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903–1915. doi:10.1056/NEJMoa066092.
  • von Hunolstein C, Ralli L, Pinto A, Stickings P, Efstratiou A, Ida C, Participants EE, Gaggioli A. Relevance and criticality in an external quality assessment for the determination of diphtheria antitoxin. J Immunol Clin Res. 2014;2:1022.
  • WHO. The immunological basis for immunization series module 2: diphtheria. Geneva: World Heallth Organization; 2009.
  • Rohatgi A. WebPlotdigitizer. 4.5th ed. Pacifica (CA); 2021.
  • Burda BU, O’-Connor EA, Webber EM, Redmond N, Perdue LA. Estimating data from figures with a web‐based program: considerations for a systematic review. Research Synthesis Methods. 2017;8(3):258–262. doi:10.1002/jrsm.1232.
  • Drevon D, Fursa SR, Malcolm AL. Intercoder reliability and validity of webplotdigitizer in extracting graphed data. Behav Modif. 2017;41(2):323–339. doi:10.1177/0145445516673998.
  • Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–939. doi:10.1016/j.jclinepi.2011.11.014.
  • Oehlert GW. A note on the delta method. Am Stat. 1992;46:27–29.
  • Rice J. Mathematical statistics and data analysis. 2nd ed. Belmont: Duxbury; 1994.
  • Skogen V, Jenum PA, Danilov E, Korolev VN, Halvorsen DS, Sjursen H. Immunity to diphtheria among children in Northern Norway and North-Western Russia. Vaccine. 2001;19(2–3):197–203. doi:10.1016/S0264-410X(00)00176-6.
  • Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-Van Spaendonck MAE, Hallander HO, Olander R, Maple PAC, De Melker HE, et al. The sero-epidemiology of diphtheria in Western Europe. Epidemiol Infect. 2000;125(1):113–125. doi:10.1017/S0950268899004161.
  • di Giovine P, Kafatos G, Nardone A, Andrews N, Olander RM, Alfarone G, Broughton K, Cohen D, Kriz B, Mikova I, et al. Comparative seroepidemiology of diphtheria in six European countries and Israel. Epidemiol Infect. 2013;141(1):132–142. doi:10.1017/S0950268812000210.
  • Trollfors B, Knutsson N, Taranger J, Mark A, Bergfors E, Sundh V, Lagergård T. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose. Eur J Pediatr. 2006;165(1):14–18. doi:10.1007/s00431-005-1763-3.
  • Swart EM, Van Gageldonk PGM, De Melker HE, Van Der Klis FR, Berbers GAM, Mollema L. Long-Term protection against diphtheria in the Netherlands after 50 years of vaccination: Results from a seroepidemiological study. PLoS ONE. 2016;11(2):e0148605. doi:10.1371/journal.pone.0148605.
  • WHO. Review of evidence on vaccine effectiveness and immunogenicity to assess the duration of protection ≥10 years after the last booster dose. SAGE; 2017 [accessed 2017 Apr]. https://www.who.int/immunization/sage/meetings/2017/april/presentations_background_docs/en/.
  • Kitamura N, Le LT, Le TTT, Nguyen H-A, Edwards T, Madaniyazi L, Bui MX, Do HT, Dang D-A, Toizumi M, et al. The seroprevalence, waning rate, and protective duration of anti-diphtheria toxoid IgG antibody in Nha Trang, Vietnam. International Journal of Infectious Diseases. 2022;116:273–280. doi:10.1016/j.ijid.2022.01.025.
  • Murhekar MV, Kamaraj P, Kumar MS, Khan SA, Allam RR, Barde PV, Dwibedi B, Kanungo S, Mohan U, Mohanty SS, et al. Immunity against diphtheria among children aged 5-17 years in India, 2017-2018: a cross-sectional, population-based serosurvey. Lancet Infect Dis. 2021;21(6):868–875. doi:10.1016/S1473-3099(20)30595-8.
  • Truelove SA, Keegan LT, Moss WJ, Chaisson LH, Macher E, Azman AS, Lessler J. Clinical and epidemiological aspects of diphtheria: a systematic review and pooled analysis. Clin Infect Dis. 2020;71(1):89–97. doi:10.1093/cid/ciz808.
  • Heyworth B, Ropp M. Diphtheria in the Gambia. J Trop Med Hyg. 1973;76:61–64.
  • Tl CP, Poole T, Petousis-Harris H, Nowlan M 2012 Antigen review for the New Zealand national immunisation schedule: diphtheria. [cited March 1, 2015]. Available from: http://ebooks.fmhs.auckland.ac.nz/2012-antigen-review-_diphtheria/.
  • Bröker M, Berti F, Schneider J, Vojtek I. Polysaccharide conjugate vaccine protein carriers as a “neglected valency” - potential and limitations. Vaccine. 2017;35(25):3286–3294. doi:10.1016/j.vaccine.2017.04.078.
  • WHO. Tetanus vaccines: WHO position paper, February 2017 - recommendations. Vaccine. 2018;36(25):3573–3575. doi:10.1016/j.vaccine.2017.02.034.